Médecine transfusionnelle

Mises à jour

Date de publication:

8 sep 2017

Le présent chapitre décrit le processus de fabrication de la plupart des produits sanguins courants (culots globulaires, plaquettes mélangées, plasma congelé, plasma-aphérèse frais congelé, plasma surnageant de cryoprécipité et cryoprécipité). Il traite aussi brièvement des indications et contre-indications, des modalités d’entreposage et de transport, de la posologie, des modes d’administration et des produits qui peuvent les remplacer.

Twitter Facebook LinkedIn Forward

Date de publication:

14 jan 2021

Administration de produits sanguins

Chapitre 9

Ce chapitre concerne les principes qui régissent une pratique transfusionnelle sécuritaire. L’objectif est de fournir un certain nombre de connaissances aux professionnels amenés à prescrire et à réaliser des transfusions de sang et de produits sanguins.

Dernière modification:

4 jan 2021

Twitter Facebook LinkedIn Forward

COVID-19 et médecine transfusionnelle

Destinée aux professionnels de la santé spécialisés en médecine transfusionnelle, cette page a pour but de leur fournir des ressources pouvant les aider dans la pratique de leur profession pendant la pandémie de COVID-19.

Activités

U of T Rounds: SCD: alloimmunization prevention and management with genetic tools

Twitter Facebook LinkedIn Forward

Quand

28 janvier, 2021 | 12:00 - 13:00

Où

Toronto/Webinar

Presented by:

Dr. Stella Chou
Associate Professor of Pediatrics
The Children's Hospital of Philadelphia
University of Pennsylvania School of Medicine

Learning Objectives:

1. Discuss the contribution of RH genetic variation to alloimmunization in patients with SCD.
2. Discuss strategies to reduce alloimmunization using genetic tools.
3. Discuss renewable sources of rare cells for antibody identification.

Topic Teaching: Thrombocytopenic Disorders

Twitter Facebook LinkedIn Forward

Quand

2 février, 2021 | 12:00 - 13:00

Où

Toronto/Webinar

More details to follow.

Note: The session is a self-approved group learning activity (Section 1) as defined by the Maintenance of Certification program of The Royal College of Physicians and Surgeons of Canada.

Topic Teaching: Immunohaematology Cases

Twitter Facebook LinkedIn Forward

Quand

9 février, 2021 | 12:00 - 13:00

Où

Toronto/Webinar

More details to follow.

Note: The session is a self-approved group learning activity (Section 1) as defined by the Maintenance of Certification program of The Royal College of Physicians and Surgeons of Canada.

Blog

Dernière modification:

18 jan 2021

Twitter Facebook LinkedIn Forward

Chief scientist Dr. Dana Devine takes on directorship at Centre for Blood Research

Dr. Devine will bring roles together to bridge discoveries into better care

Dernière modification:

13 jan 2021

Twitter Facebook LinkedIn Forward

Dr. Celina Montemayor-Garcia on the potential of genomics to shape the future of transfusion medicine

Dr. Celina Montemayor-Garcia is a researcher and transfusion medicine specialist whose main interest is understanding how genomics and bioinformatics can be used to improve care for transfusion patients. She spoke to us about advances in precision medicine and genomics, and what they could mean for the future of blood systems.

Dernière modification:

11 jan 2021

Twitter Facebook LinkedIn Forward

Breaking barriers to effective treatment for Alzheimer’s disease

Blood plasma-derived IVIg holds promise as a treatment for Alzheimer’s disease. A new study suggests that combining IVIg with a new drug delivery technique that helps get IVIg into the brain could increase its effectiveness and help make the best use of this precious treatment.